hesperidin has been researched along with labetalol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Carbajo, RJ; Gozalbes, R; Melnyk, P; Mosulén, S; Ortí, L; Pineda-Lucena, A; Rodríguez-Díaz, J | 1 |
3 other study(ies) available for hesperidin and labetalol
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Hit identification of novel heparanase inhibitors by structure- and ligand-based approaches.
Topics: Amodiaquine; Antimalarials; Binding Sites; Catalytic Domain; Drug Design; Glucuronidase; Humans; Ligands; Molecular Docking Simulation; Nuclear Magnetic Resonance, Biomolecular; Quantitative Structure-Activity Relationship; Recombinant Proteins; Structure-Activity Relationship | 2013 |